Group 1 - The core viewpoint is that the domestic brain-computer interface (BCI) industry in China has surpassed 650 companies, with a significant shift towards the medical and health sector due to increasing demand from patients with neurological diseases [1][2] - The number of newly registered BCI companies in China increased by approximately 50% year-on-year in 2025, indicating a growing interest and investment in this field [1] - Major players like OpenAI's Sam Altman and Elon Musk's Neuralink are driving the global interest in BCIs, with Neuralink announcing plans for device mass production within the year [1] Group 2 - The transition from consumer applications to medical health is driven by the rising number of patients suffering from conditions like stroke and Parkinson's disease, which traditional medical methods struggle to address [2] - There are significant challenges in making BCI technology widely accessible, including the high cost of invasive devices exceeding 500,000 yuan and the economic burden of non-invasive products on some families [2] - A call for a multi-faceted payment system involving medical insurance, commercial insurance, and personal payments has been made to alleviate financial pressures on patients [2]
国内脑机接口相关企业超650家,脑机接口商业化转向医疗健康领域
Xin Lang Cai Jing·2026-02-05 12:18